Addus HomeCare price target raised to $141 from $137 at TD Cowen

TD Cowen raised the firm’s price target on Addus HomeCare (ADUS) to $141 from $137 and keeps a Buy rating on the shares. The firm said its earnings beat was driven primarily by higher total product sales ( 8%) where HIV ( 5%) and Veklury ( 150%) were the biggest contributors.